In May 2021, which of the following has received approval from the Director-General of Health Services (DGHS) to manufacture and market Favipiravir tablets in India?

In May 2021, which of the following has received approval from the Dir

1.	In May 2021, which of the following has received approval from the Director-General of Health Services (DGHS) to manufacture and market Favipiravir tablets in India?
A.	Nectar Lifesciences
B.	Morepen Laboratories Ltd.
C.	Vivimed Labs
D.	Glenmark Pharmaceuticals
E.	Natco Pharma
Answer» D. Glenmark Pharmaceuticals